How Does a Drug Get Reimbursed in Iran?

Published Jun 3, 2014
Rotterdam, the Netherlands & Tehran, Iran – Researchers at the Institute for Medical Technology Assessment sought out to examine and describe the Iranian decision-making process regarding drug reimbursement and the role of the main stakeholders in this process. In the study, “Drug regulatory and reimbursement system in Iran,” the researchers revealed the pathway towards reimbursement. The decision-making process for reimbursing drugs in Iran is split between two ministries: the Ministry of Health and Medical Education and the Ministry of Welfare and Social Security. Ultimately, the Iranian Cabinet approves a drug and recommends its use to all health insurance organizations. Despite its strengths, the system faces various issues, including conflicting stakeholder aims, lengthy decision making, limited access to decision-making details and rigidity in the assessment process. Amir Ansaripour, PharmD, a researcher at Erasmus University, states that, “Iranian policy makers need to reevaluate how new drugs are added to the reimbursement lists and possibly create a more efficient regulatory body.”

Value in Health Regional Issues (ISSN 2212-1099) is a scientific journal that encourages and enhances the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions. The journal is published up to three times a year with one issue focusing on the Asia region, one issue focusing on the Latin America region, and one issue focusing on the Central & Eastern Europe, Western Asia and Africa regions.

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

Follow Value in Health Regional Issues on Twitter: @ISPORJournals

Related Stories

Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model

Jan 23, 2024

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries

Jan 22, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score

Aug 7, 2023

Value in Health Regional Issues, the regionally focused journal of ISPOR, received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list of scholarly journals.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now